Frontier Medicines Presents New Preclinical Data on its Deve

Frontier Medicines Presents New Preclinical Data on its Development Candidate, FMC-376, a Dual KRASG12C Inhibitor, at the 2023 AACR Annual Meeting

Frontier Medicines Presents New Preclinical Data on its Development Candidate, FMC-376, a Dual KRASG12C Inhibitor, at the 2023 AACR Annual Meeting
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Related Keywords

Boston , Massachusetts , United States , Florida , Orlando , American , Chris Varma , Twitter , Frontier Medicines Corporation , Corporate Affairs , Linkedin , American Association For Cancer Research , Medicines Corporation , Cancer Research , Annual Meeting , Investigational New Drug , Frontier Medicinesfrontier Medicines , Media Relations Contact ,